Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro, +166

The Lancet

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi, +191

The Lancet

Hematological MalignancyBone Marrow FailureMomelotinib Versus DanazolSymptomatic PatientsHematology +4

Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern

Inbal Farkash, Tali Feferman, Noy Cohen Saban, +11

Cell Reports

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine

H Maayan, Ilya Kirgner, Odit Gutwein, +4

Journal of Thrombosis and Haemostasis

VaccinationThrombosisBnt162b2 VaccineAutoimmune DiseaseVaccine Development +7

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

David J. Kuter, Waleed Ghanima, Nichola Cooper, +28

Blood

Characteristics and outcomes of young adults with Philadelphia‐negative myeloproliferative neoplasms

Merav Barzilai, Ilya Kirgner, Irit Avivi, +4

European Journal Of Haematology

Replication Pattern in Cancer

Aliza Amiel, Ilya Kirgner, E. Gaber, +3

Cancer Genetics and Cytogenetics

Tumor HeterogeneityMedicineCancer RecurrencePathologyReplication Pattern +3

Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials

Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, Aaron T. Gerds, +16

HemaSphere

Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma

Erel Joffe, Dana Rosenberg, Uri Rozovski, +10

Bone Marrow Transplantation

B-cell LymphomaLymphoid NeoplasiaCell TherapyTransplantationMarrow Transplantation +8

Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients

Yael Lichter, Tanya Badelbayov, Irina Shalev, +12

Thrombosis Journal